EBR Systems (EBRDA) Stock Overview

Develops implantable systems for wireless tissue stimulation. More details

EBRDA fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	2/6
Past Performance	0/6
Financial Health	4/6
Dividends	0/6

Rewards

Trading at 89.2% below our estimate of its fair value

Revenue is forecast to grow 43.29% per year

Risk Analysis

Has less than 1 year of cash runway

Shares are highly illiquid

Currently unprofitable and not forecast to become profitable over the next 3 years

Does not have meaningful revenue ($2M)

+ 1 more risk

EBRDA Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View all narratives

EBR Systems, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for EBR Systems
Historical stock prices
Current Share Price	AU$0.67
52 Week High	AU$0.74
52 Week Low	AU$0.57
Beta	0.56
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	9.84%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	EBRDA	AU Medical Equipment	AU Market
7D	13.6%	0.8%	4.3%
1Y	n/a	-22.6%	16.2%

Return vs Industry: Insufficient data to determine how EBRDA performed against the Australian Medical Equipment industry.

Return vs Market: Insufficient data to determine how EBRDA performed against the Australian Market.

Price Volatility

Is EBRDA's price volatile compared to industry and market?
EBRDA volatility
EBRDA Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	10.7%
Market Average Movement	10.5%
10% most volatile stocks in AU Market	17.8%
10% least volatile stocks in AU Market	4.5%

Stable Share Price: EBRDA's share price has been volatile over the past 3 months compared to the Australian market.

Volatility Over Time: Insufficient data to determine EBRDA's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2003	135	John McCutcheon	www.ebrsystemsinc.com

EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. It offers WiSE cardiac resynchronization therapy system, an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of leads; and stimulation of the left ventricular endocardium for cardiac resynchronization therapy (SOLVE-CRT), an investigational device exemption. The company was incorporated in 2003 and is headquartered in Sunnyvale, California.

EBR Systems, Inc. Fundamentals Summary

How do EBR Systems's earnings and revenue compare to its market cap?
EBRDA fundamental statistics
Market cap	AU$261.32m
Earnings (TTM)	-AU$68.89m
Revenue (TTM)	AU$2.28m

114.4x

P/S Ratio

-3.8x

P/E Ratio

Is EBRDA overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
EBRDA income statement (TTM)
Revenue	US$1.62m
Cost of Revenue	US$1.13m
Gross Profit	US$490.00k
Other Expenses	US$49.25m
Earnings	-US$48.76m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	-0.11
Gross Margin	30.30%
Net Profit Margin	-3,015.34%
Debt/Equity Ratio	159.8%

How did EBRDA perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/04/11 21:01
End of Day Share Price	2026/04/10 00:00
Earnings	2025/12/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

EBR Systems, Inc. is covered by 4 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
John Hester	Bell Potter
Martyn Jacobs	Bell Potter
Madeleine Williams	Canaccord Genuity